Which are the optimal thromboprophylaxis strategies for hospitalized patients with COVID-19? current controversies.

ABSTRACT: Novel coronavirus 2019 (COVID-19) represents a significant risk factor for the development of venous thromboembolism (VTE) in hospitalized with both moderate and severe/critical COVID-19. Herein, we present a brief updated review on emerging robust data on diverse thromboprophylaxis strategies used to mitigate VTE complications, as well as a personal point of view of current controversies in regards the use of therapeutic and prophylactic anticoagulation strategies, particularly in the moderately-ill subgroup of patients with COVID-19.

SUBMITTER: Porres-Aguilar M 

PROVIDER: S-EPMC9459371 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature